Leading cryptocurrencies slipped on Thursday, even as key stock barometers rose, amid heightened expectations of interest rate cuts.

Cryptocurrency	Gains +/-	Price (Recorded at 8:25 p.m. ET)
Bitcoin (CRYPTO: BTC)	-1.04%	$92,460.85
Ethereum (CRYPTO: ETH)	-1.77%	$3,156.33
XRP (CRYPTO: XRP)	-4.30%	$2.10
Solana (CRYPTO: SOL)	-4.40%	$139.58
Dogecoin (CRYPTO: DOGE)	-2.75%	$0.1480

Crypto Rebound Loses Momentum

Bitcoin rebound lost steam as the apex cryptocurrency consolidated in the $91,000-$92,000 range. Trading volume fell 19% over the last 24 hours.

Ethereum attempted to break $3,220 but faced sharp rejection, tumbling to $3,070. The second-largest cryptocurrency regained some ground overnight.

Shares of cryptocurrency-linked stocks such as Strategy Inc. (NASDAQ:MSTR) and Coinbase Global Inc. (NASDAQ:COIN) closed down 1.26% and 1.04%, respectively, during the regular trading session.

Benzinga Edge delivers real-time stock alerts, trade ideas, and professional investing tools to help you navigate the market. Find out more about MSTR and BMNR here.

Cryptocurrency liquidations reached $266 million over the last 24 hours, according to Coinglass, with long liquidations amounting to nearly $80 million.

That said, over $440 million in Bitcoin short positions risked liquidation if the apex cryptocurrency reclaimed $95,000.

Bitcoin's open interest fell 0.48% in the last 24 hours, roughly matching the dip in spot price.

Alice Liu, Head of Research at CoinMarketCap, on Tuesday said that crypto has entered a phase of high fear and high volatility, and warned that Bitcoin’s next true expansion cycle may not arrive until 2026.

Top Gainers (24 Hours)

Cryptocurrency (Market Cap>$100 M)	Gains +/-	Price (Recorded at 8:25 p.m. ET)
SpaceN (SN )	+78.08%	$4.10
Decred (DCR)	+22.20%	$0.6065
Zcash (ZEC )	+10.87%	$387.69

The global cryptocurrency market capitalization stood at $3.14 trillion, following a decrease of 0.92% in the last 24 hours.

S&P 500 Extends Rally

Major stock indexes extended their gains on Thursday. The S&P 500 gained 0.11% to close at 6,857.12. The tech-focused Nasdaq Composite closed up 0.22% to settle at 23,505.14.

The Dow Jones Industrial Average was the outlier, dropping 31.96 points, or 0.07%, to end at 47,850.94.

The drop in private payrolls for November suggested a cooling labor market, leading investors to increasingly bet on a more dovish stance on monetary policy.

The CME FedWatch tool now shows an 87% chance of a 25-basis-point cut next week.

Why This Bitcoin Resistance Level Is Important

Popular cryptocurrency analyst and trader Michaël van de Poppe identified $3,100-$3,150 as a key resistance level for Ethereum, expressing a desire to see it turn into a support zone.

"Well, it does say that buyers are willing to be stepping in on higher grounds than last week and that would signal a potential rally to $3,700," the analyst added.

I'd love to see $ETH hold this previous resistance zone as support.

What does that say?

Well, it does say that buyers are willing to be stepping in on higher grounds than last week and that would signal a potential rally to $3,700. pic.twitter.com/tWjrviMBZq
— Michaël van de Poppe (@CryptoMichNL) December 4, 2025

Byzantine General, another widely followed cryptocurrency commentator on X, highlighted approximately $92,000 as a key resistance level for Bitcoin.

"If it breaks through it could fly over a $100,000 very quickly, but if it actually rejects here then we’re probably stuck in this $92,000 – $82,000 range for a while," the analyst projected.

$BTC is struggling a bit here at this key resistance level.

If it breaks through it could fly over a 100k very quickly, but if it actually rejects here then we're probably stuck in this 92k – 82k range for a while. pic.twitter.com/ycijAtpLFO
— Byzantine General (@ByzGeneral) December 4, 2025

Photo Courtesy: vinnstock on Shutterstock.com

Read Next:

Does The Fusaka Upgrade Put A Floor On Ethereum Prices?

Benzinga

Benzinga

Beximco Pharmaceuticals PLC Stock News

Latest Beximco Pharmaceuticals Stock News | OTC:BXMPY | Benzinga

Latest Beximco Pharmaceuticals Stock News | OTC:BXMPY | Benzinga